Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock
SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.30+0.06 (+1.42%)
Close on Nov 17, 2026Market cap $4.31MP/E –Yield –
Shuttle Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Shuttle Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.58M. For fiscal 2025 it was -$9.48M. The highest annual figure on record is -$300.34K in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.48M | – |
| FY2024 | Dec 31, 2024 | -$7.33M | – |
| FY2023 | Dec 31, 2023 | -$5.58M | – |
| FY2022 | Dec 31, 2022 | -$2.67M | – |
| FY2021 | Dec 31, 2021 | -$300.34K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$567.64K | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.42M | – |
| Q4 FY2025 | Dec 31, 2025 | -$973.01K | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.63M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.36M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.53M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.69M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.00M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.40M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.24M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.06M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.53M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.65M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.34M | – |
| Q4 FY2022 | Dec 31, 2022 | -$635.82K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$355.42K | – |
| Q1 FY2022 | Mar 31, 2022 | -$624.61K | – |
| Q4 FY2021 | Dec 31, 2021 | -$135.15K | – |
See a number that looks wrong?